Thermo- and pH-Responsive, Coacervate-Forming Hyperbranched Poly(β-amino ester)s for Selective Cell Binding
Source abstract
Abstract
We report a new type of thermo- and pH-responsive, coacervate-forming highly degradable polymer-hyperbranched poly(β-amino esters) (HPAEs) and its selective cell binding behaviors. The HPAEs were synthesized from 5-amino-1-pentanol (S5) and trimethylolpropane ethoxylate triacrylate (TMPETA) via an A2+B3 type Michael addition. The existence of multiple hydrogen bond pairs as well as tertiary amines makes the S5-TMPETA polymers manifest temperature- and pH-dependent phase transition. By varying the length of the ethylene glycol (EG) spacers in the TMPETA, polymer molecular weight, concentration, and pH value, the phase transition of the S5-TMPETA can be easily tuned in aqueous and buffer solutions, as evidenced by UV-vis spectroscopy and DLS measurements. Especially, the S5-TMPETA prepared from S5 and trimethylolpropane ethoxylate triacrylate 692 (S5-TMPETA692) shows a lower critical solution temperature (LCST) around 33 °C, above which the S5-TMPTEA can form coacervate particles able to encapsulate functional molecules effectively. Importantly, when incubation with HeLa cells, the S5-TMPTETA692 exhibits a temperature- and pH-responsive selective cell binding behaviors. In addition, the S5-TMPETA are highly hydrolyzable and elicit negligible cytotoxicity. This new type of "smart" polymer should find use in a variety of biomedical applications.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Dendrimers and Hyperbranched Polymers · Polymer Surface Interaction Studies · Advanced Polymer Synthesis and Characterization
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Charles Institute of Dermatology, School of Medicine, University College Dublin, Dublin 4, Ireland
School of Materials Science and Engineering, Sichuan University, Chengdu 610064, China
School of Materials Science and Engineering, Tianjin University, Tianjin 300072, China
Funding
Science Foundation Ireland · Health Research Board
References (72)
Show source-provided references
1. 10.1021/ar600053g10.1021/ar600053g ↗
2. 10.1021/nn800332g10.1021/nn800332g ↗
3. 10.1021/ja510147n10.1021/ja510147n ↗
4. 10.1002/1521-3773(20010504)40:9<1707::AID-ANIE17070>3.0.CO;2-F10.1002/1521-3773(20010504)40:9<1707::AID-ANIE17070>3.0.CO;2-F ↗
5. 10.1039/c3cc48733d10.1039/c3cc48733d ↗
6. 10.1021/ja507626y10.1021/ja507626y ↗
7. 10.1038/nmat261410.1038/nmat2614 ↗
8. 10.1016/j.progpolymsci.2009.10.00810.1016/j.progpolymsci.2009.10.008 ↗
9. 10.1016/j.addr.2006.09.02010.1016/j.addr.2006.09.020 ↗
10. 10.1021/nl200832c10.1021/nl200832c ↗
11. 10.1021/bm034139o10.1021/bm034139o ↗
12. 10.1021/am302820y10.1021/am302820y ↗
13. 10.1039/c3cs35499g10.1039/c3cs35499g ↗
14. 10.1016/j.jconrel.2013.10.03510.1016/j.jconrel.2013.10.035 ↗
15. 10.1002/adma.20120257410.1002/adma.201202574 ↗
16. 10.1021/am400572b10.1021/am400572b ↗
17. 10.1002/anie.20120795310.1002/anie.201207953 ↗
18. 10.1016/j.ijpharm.2014.06.02910.1016/j.ijpharm.2014.06.029 ↗
19. 10.1016/j.jconrel.2005.08.00910.1016/j.jconrel.2005.08.009 ↗
20. 10.1021/acs.macromol.5b0058510.1021/acs.macromol.5b00585 ↗
21. 10.1039/c3py00218g10.1039/c3py00218g ↗
22. 10.1039/c4py00155a10.1039/c4py00155a ↗
23. 10.1039/C2CS35191A10.1039/C2CS35191A ↗
24. 10.1016/0079-6700(92)90023-R10.1016/0079-6700(92)90023-R ↗
25. 10.1002/anie.20090160710.1002/anie.200901607 ↗
26. 10.1016/j.addr.2007.08.01810.1016/j.addr.2007.08.018 ↗
27. 10.1021/acs.langmuir.5b0200610.1021/acs.langmuir.5b02006 ↗
28. 10.1039/c2cs35078e10.1039/c2cs35078e ↗
29. 10.1021/jp015514e10.1021/jp015514e ↗
30. 10.1021/j100345a08510.1021/j100345a085 ↗
31. 10.1007/3-540-56791-7_110.1007/3-540-56791-7_1 ↗
32. 10.1038/373049a010.1038/373049a0 ↗
33. 10.1021/ma00062a01610.1021/ma00062a016 ↗
34. 10.1021/ja01000a00610.1021/ja01000a006 ↗
35. 10.1021/ma010296910.1021/ma0102969 ↗
36. 10.1021/ma000928b10.1021/ma000928b ↗
37. 10.1021/ma071203b10.1021/ma071203b ↗
38. 10.1039/B406727D10.1039/B406727D ↗
39. 10.1021/ma012093q10.1021/ma012093q ↗
40. 10.1021/ma802671a10.1021/ma802671a ↗
41. 10.1021/la001346q10.1021/la001346q ↗
42. Neradovic D. · J. Controlled Release · 2001 · 72 · 252
43. 10.1021/ma047393x10.1021/ma047393x ↗
44. 10.1002/anie.20150666310.1002/anie.201506663 ↗
45. 10.1038/1510010.1038/15100 ↗
46. 10.1039/b210181e10.1039/b210181e ↗
47. 10.1126/sciadv.160010210.1126/sciadv.1600102 ↗
48. 10.1021/acs.biomac.5b0096610.1021/acs.biomac.5b00966 ↗
49. 10.1039/C5CC02193F10.1039/C5CC02193F ↗
50. 10.1016/j.jconrel.2016.06.01410.1016/j.jconrel.2016.06.014 ↗
51. 10.1021/ar700233610.1021/ar7002336 ↗
52. 10.1073/pnas.090543210610.1073/pnas.0905432106 ↗
53. 10.1021/ja034429c10.1021/ja034429c ↗
54. 10.1021/ja001538810.1021/ja0015388 ↗
55. 10.1073/pnas.040721810110.1073/pnas.0407218101 ↗
56. 10.1021/bm400466e10.1021/bm400466e ↗
57. 10.1016/j.biomaterials.2013.09.05210.1016/j.biomaterials.2013.09.052 ↗
58. 10.1038/nbt117110.1038/nbt1171 ↗
59. 10.1021/ja047755g10.1021/ja047755g ↗
60. 10.1002/pola.2187810.1002/pola.21878 ↗
61. 10.1039/c1py00053e10.1039/c1py00053e ↗
62. 10.1021/ja054542y10.1021/ja054542y ↗
63. 10.1002/mabi.20150011110.1002/mabi.201500111 ↗
64. 10.1088/1748-6041/11/2/02500210.1088/1748-6041/11/2/025002 ↗
65. 10.1021/ma981590c10.1021/ma981590c ↗
66. 10.1021/ma980771b10.1021/ma980771b ↗
67. 10.1021/ma021328a10.1021/ma021328a ↗
68. 10.1021/ma002223f10.1021/ma002223f ↗
69. 10.1039/b309487a10.1039/b309487a ↗
70. 10.1021/bm034215n10.1021/bm034215n ↗
71. 10.1021/ja054642410.1021/ja0546424 ↗
72. 10.1038/nmat327210.1038/nmat3272 ↗